Sign in
bf/NASDAQ:MLTX_icon.jpeg

NASDAQ:MLTX

MoonLake Immunotherapeutics

  • Stock

USD

Last Close

44.91

26/07 20:00

Market Cap

2.83B

Beta: 0.94

Volume Today

84.49K

Avg: 309.57K

PE Ratio

−64.99

PFCF: −87.07

OverviewFinancialsFilingspeopleOwnershipAPIChartData

  • locale

    chSwitzerland

  • market

    STOCKS

  • industry

    Biotechnology

  • website

    www.moonlaketx.com

  • ipo date

    Oct 20, 2020

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis...Show More

Excel Tearsheet

peer of

Earnings

Earnings Release in 12 days

Earnings per Share (Estimate*)

-0.8-0.6-0.4-0.22021-03-312022-02-172022-11-142023-08-102024-05-12

Revenue (Estimate*)

0.000.000.010.010.012021-03-312022-02-172022-11-142023-08-102024-05-12

*Estimate based on analyst consensus